These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9287248)

  • 1. Multidrug resistance: molecular and clinical aspects.
    Dicato M; Duhem C; Pauly M; Ries F
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):91-9. PubMed ID: 9287248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance in pediatric malignancies.
    Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
    Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of multidrug resistance in tumor cells.
    Roninson IB
    Clin Physiol Biochem; 1987; 5(3-4):140-51. PubMed ID: 2887329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo.
    Licht T; Gottesman MM; Pastan I
    Cytokines Mol Ther; 1995 Mar; 1(1):11-20. PubMed ID: 9384659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redundancy of biological regulation as the basis of emergence of multidrug resistance.
    Shtil AA; Azare J
    Int Rev Cytol; 2005; 246():1-29. PubMed ID: 16164965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
    Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
    Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the multidrug resistance (MDR1) gene expression.
    Chin KV; Liu B
    In Vivo; 1994; 8(5):835-41. PubMed ID: 7727733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein in adult solid tumors. Expression and prognostic significance.
    Leighton JC; Goldstein LJ
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):251-73. PubMed ID: 7642464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoresistance and multiple myeloma: from biological to clinical aspects.
    Rossi JF
    Stem Cells; 1995 Aug; 13 Suppl 2():64-71. PubMed ID: 8520514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
    Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
    Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the multidrug-transporter P-glycoprotein by 3'-azido-3'-deoxythymidine (AZT) treatment in tumor cell lines.
    Signoretti C; Romagnoli G; Turriziani O; Antonelli G; Dianzani F; Cianfriglia M
    J Exp Clin Cancer Res; 1997 Mar; 16(1):29-32. PubMed ID: 9148857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.